Announcements
Projects
Orgs
Project
Articles 49
Votes 0
FierceBiotech

Authors 9

Ben Adams
Helen Floersh
FierceBiotech
James Waldron
Max Bayer
Nick Paul Taylor
Darren Incorvaia
Conor Hale
Gabrielle Masson
BMS trims anti-TIGIT and a handful of other meds - FierceBiotech
>2y
BMS trims anti-TIGIT and a handful of other meds - FierceBiotech
>2y
Italian billionaires behind Ferrari, Juventus drop $2.8B to become Philips' largest shareholder - FierceBiotech
>2y
One injection to cure sickle cell? Researchers give it a shot with new mRNA gene therapy - FierceBiotech
>2y
Sanofi, BioNTech cull mRNA clinical cytokine cancer candidate based on early data - FierceBiotech
>2y
CRISPR helps solve 100-year mystery of why cancer cells have extra chromosomes - FierceBiotech
>2y
First-gen mRNA flu vaccines 'will not win,' Sanofi execs admit as they retool strategy - FierceBiotech
>2y
It's 'a concern': Bavarian Nordic flags worrying COVID-19 vaccine result ahead of phase 3 data drop - FierceBiotech
>2y
Illumina CEO Francis deSouza resigns following proxy battle with Carl Icahn - FierceBiotech
>2y
J&J's multiple myeloma combo produces 96% Carvykti-like response - FierceBiotech
>2y
Gilead and Arcus' TIGIT combo continues to show signs of life - FierceBiotech
>2y
New RNA biotech raises $300M in largest private round of 2023 - FierceBiotech
>2y
Novartis to buy Avrobio gene therapy for $88M, leaving rest of the biotech on the shelf - FierceBiotech
>2y
UPDATED: Sarepta rewarded by Wall Street for FDA committee shocker, with accelerated nod now more likely - FierceBiotech
>2y
All the rumors are true: Syneos snapped up for $7.1B - FierceBiotech
>2y
Dual CRISPR therapy plus long-acting ART eliminates HIV in mice - FierceBiotech
almost3y
Novartis prunes assets, axing 10% of pipeline programs to narrow R&D focus - FierceBiotech
almost3y
Revolo drops dab of midphase data on would-be Dupixent rival - FierceBiotech
almost3y
New test detects Parkinson's biomarker before movement symptoms start - FierceBiotech
almost3y
Returning the complement: Protein's role in pathway could bolster new Alzheimer's approach - FierceBiotech
almost3y
Pear Therapeutics exploring a sale amid hemorrhaging costs - FierceBiotech
almost3y
Targeted protein degradation improves cognition and reduces Alzheimer's brain pathology in mouse models - FierceBiotech
almost3y
Protalix, Chiesi edge close to potential Fabry disease approval
>5y
Another Alexion alum joins Rallybio ranks
>5y